跳至主要内容
临床试验/NCT07507955
NCT07507955尚未招募不适用

To Evaluate the Efficacy and Safety of Probiotics in Alleviating Constipation in Adults Through a Randomized, Double-blind, Placebo-controlled Trial

Wecare Probiotics Co., Ltd.1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2026年6月10日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
105
试验地点
1

研究概览

简要总结

This study aims to evaluate the efficacy and safety of Bifidobacterium animalis subsp. lactis BLa36 in adults with functional constipation. In this randomized, double-blind, placebo-controlled trial, participants will receive BLa36 supplementation or placebo for 8 weeks. Clinical outcomes will be assessed using validated gastrointestinal symptom scales, stool characteristics, and quality-of-life measures. In addition, changes in inflammatory and immune markers, gut microbiota composition, metabolic indicators, and gut-brain axis-related parameters will be evaluated to comprehensively determine the effects of BLa36 on intestinal function and overall health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18-65 years;
  • Individuals diagnosed with constipation, defined as fewer than 3 bowel movements per week and/or Bristol Stool Form Scale (BSFS) types 1-2;
  • Able and willing to comply with all study procedures and complete the study;
  • Provided written informed consent prior to participation;
  • Participants (including males) must have no intention of conception from 14 days before screening until 6 months after study completion and agree to use effective contraception.

排除标准

  • Recent use of products with similar effects that may interfere with study outcomes; Significant dietary changes during the study period;
  • History of severe allergy or immunodeficiency;
  • Pregnant or breastfeeding women, or those planning pregnancy;
  • Presence of serious systemic diseases (e.g., cardiovascular, pulmonary, hepatic, renal, endocrine, or malignant conditions);
  • Use of antibiotics within the past 2 weeks;
  • Individuals with severe psychiatric or neurological disorders;
  • Poor compliance, including failure to take the study product or attend scheduled visits;
  • Any other condition deemed unsuitable by the investigator.

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验